P
Paracel Explorer
Dernière publication·Octobre 2026

Kanjinti

Trastuzumabum — subst sèche 150 mg

Amgen Switzerland AG

ATCL01FD01
Swissmedic67205
Dossier21018
Remboursement
QP 10%PMKG
Modifications (17)